{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:21:32Z","timestamp":1793467292378,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clineuro.2018.07.001","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T17:54:15Z","timestamp":1530986055000},"page":"151-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Management of leptomeningeal metastasis in breast cancer"],"prefix":"10.1016","volume":"172","author":[{"given":"Hazem I.","family":"Assi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tala","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi S.","family":"Saadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidar","family":"El Darsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2018.07.001_bib0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/CCO.0b013e32833de986","article-title":"Leptomeningeal metastasis","volume":"22","author":"Chamberlain","year":"2010","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/archneur.1997.00550130008003","article-title":"Carcinomatous meningitis","volume":"54","author":"Chamberlain","year":"1997","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.hoc.2012.04.004","article-title":"Neoplastic meningitis and metastatic epidural spinal cord compression","volume":"26","author":"Chamberlain","year":"2012","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0020","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4103\/0019-509X.175351","article-title":"Leptomeningeal metastasis in solid tumors with a special focus on lung cancer","volume":"51","author":"Joshi","year":"2014","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0025","doi-asserted-by":"crossref","first-page":"iv84","DOI":"10.1093\/annonc\/mdx221","article-title":"EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours","volume":"28","author":"Le Rhun","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","article-title":"Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients","volume":"49","author":"Wasserstrom","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0035","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1212\/WNL.29.10.1369","article-title":"Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology","volume":"29","author":"Glass","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0040","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.seminoncol.2009.05.005","article-title":"Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment","volume":"36","author":"Chamberlain","year":"2009","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0045","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archneurol.2010.18","article-title":"New strategies in the management of leptomeningeal metastases","volume":"67","author":"Groves","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-007-9340-4","article-title":"Breast cancer leptomeningeal metastasis--the role of multimodality treatment","volume":"84","author":"Rudnicka","year":"2007","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0055","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.18632\/oncotarget.5911","article-title":"Leptomeningeal metastasis in breast cancer\u2013a systematic review","volume":"7","author":"Scott","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.nrl.0000219732.33321.cc","article-title":"Neoplastic meningitis","volume":"12","author":"Chamberlain","year":"2006","journal-title":"Neurologist"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0065","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4155\/cli.11.115","article-title":"Neoplastic meningitis resulting from hematological malignancies: pharmacokinetic considerations and maximizing outcome","volume":"1","author":"Grewal","year":"2011","journal-title":"Clin. Investig. Lond."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0070","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11060-018-2790-z","article-title":"Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM)","volume":"138","author":"Niwi\u0144ska","year":"2018","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cncr.30911","article-title":"Leptomeningeal metastasis from systemic cancer: review and update on management","volume":"124","author":"Wang","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0080","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cell.2017.02.025","article-title":"Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis","volume":"168","author":"Boire","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/0-387-24199-X_2","article-title":"Leptomeningeal neoplasia: epidemiology, clinical presentation, CSF analysis and diagnostic imaging","volume":"125","author":"Enting","year":"2005","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0090","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z","article-title":"Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results","volume":"82","author":"Glantz","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/neuonc\/3.1.42","article-title":"A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases","volume":"3","author":"Chamberlain","year":"2001","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/0-387-24199-X_3","article-title":"Leptomeningeal metastases from solid tumors (meningeal carcinomatosis)","volume":"125","author":"Bruno","year":"2005","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11060-014-1361-1","article-title":"CSF CA 15-3 in breast cancer-related leptomeningeal metastases","volume":"117","author":"Le Rhun","year":"2014","journal-title":"J. Neurooncol."},{"issue":"Suppl. 4","key":"10.1016\/j.clineuro.2018.07.001_bib0110","doi-asserted-by":"crossref","first-page":"iv285","DOI":"10.1093\/annonc\/mdh941","article-title":"The diagnostic and therapeutic management of leptomeningeal carcinomatosis","volume":"15","author":"Pavlidis","year":"2004","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0115","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/(SICI)1097-0142(19980415)82:8<1419::AID-CNCR1>3.0.CO;2-4","article-title":"Utilization of polymerase chain reaction technology in the detection of solid tumors","volume":"82","author":"Raj","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clinbiochem.2003.11.005","article-title":"Mammaglobin: a candidate diagnostic marker for breast cancer","volume":"37","author":"Zehentner","year":"2004","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11060-008-9711-5","article-title":"Molecular detection of human mammaglobin in cerebrospinal fluid from breast cancer patient with leptomeningeal carcinomatosis","volume":"91","author":"Dono","year":"2009","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-009-9819-2","article-title":"Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma","volume":"94","author":"Groves","year":"2009","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0135","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/neuonc\/nos074","article-title":"MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity","volume":"14","author":"Teplyuk","year":"2012","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0140","doi-asserted-by":"crossref","first-page":"752","DOI":"10.18632\/oncotarget.336","article-title":"Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases","volume":"2","author":"Patel","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0145","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/neuonc\/nox066","article-title":"Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors","volume":"19","author":"Lin","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0150","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1634\/theoncologist.8-5-398","article-title":"Diagnosis and management of central nervous system metastases from breast cancer","volume":"8","author":"Chang","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/WNL.55.1.117","article-title":"Response of leptomeningeal metastases from breast cancer to hormonal therapy","volume":"55","author":"Boogerd","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0160","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1148\/radiology.217.1.r00oc3550","article-title":"Intracranial leptomeningeal metastases: comparison of depiction at FLAIR and contrast-enhanced MR imaging","volume":"217","author":"Singh","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00004728-199003000-00018","article-title":"Leptomeningeal metastases: MR evaluation","volume":"14","author":"Yousem","year":"1990","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0170","first-page":"386","article-title":"Schilder\u2019s disease: neuroradiological findings","volume":"15","author":"Rodesch","year":"1988","journal-title":"J. Neuroradiol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0175","series-title":"Diseases of the Breast","first-page":"867","article-title":"Leptomeningeal metastasis","author":"De Angelis","year":"2000"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0180","first-page":"817","article-title":"MR imaging of leptomeningeal metastases: comparison of three sequences","volume":"23","author":"Singh","year":"2002","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0185","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","article-title":"Metastatic behavior of breast cancer subtypes","volume":"28","author":"Kennecke","year":"2010","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0190","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10549-011-1682-0","article-title":"Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations","volume":"129","author":"Lee","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0195","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1002\/cncr.27581","article-title":"Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network","volume":"118","author":"Lin","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11060-013-1083-9","article-title":"The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer","volume":"112","author":"Sperduto","year":"2013","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0205","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijrobp.2014.06.063","article-title":"Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgery","volume":"90","author":"Yang","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clbc.2016.07.002","article-title":"Characteristics and outcomes of patients with breast cancer with leptomeningeal metastasis","volume":"17","author":"Morikawa","year":"2017","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0215","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1200\/JCO.2006.07.0250","article-title":"Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer","volume":"24","author":"Gabos","year":"2006","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0220","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/cncr.25771","article-title":"Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study","volume":"117","author":"Musolino","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0225","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/annonc\/mdn036","article-title":"Defining prognosis for women with breast cancer and CNS metastases by HER2 status","volume":"19","author":"Dawood","year":"2008","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0230","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ctrv.2012.05.006","article-title":"Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier","volume":"39","author":"Mehta","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0235","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11060-010-0524-y","article-title":"Meningeal carcinomatosis in breast cancer: prognostic factors and outcome","volume":"104","author":"de Azevedo","year":"2011","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0240","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1200\/JCO.2000.18.11.2349","article-title":"Trastuzumab in CSF","volume":"18","author":"Pestalozzi","year":"2000","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.cad.0000236313.50833.ee","article-title":"Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier","volume":"18","author":"Stemmler","year":"2007","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0250","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.2010.12","article-title":"Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer","volume":"87","author":"Dijkers","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0255","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11912-003-0083-x","article-title":"Standard and novel radiotherapeutic approaches to neoplastic meningitis","volume":"5","author":"Chang","year":"2003","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0260","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/archneur.55.4.506","article-title":"Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy","volume":"55","author":"Chamberlain","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0265","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1634\/theoncologist.2008-0138","article-title":"Neoplastic meningitis","volume":"13","author":"Chamberlain","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0270","first-page":"26","article-title":"Management of neoplastic meningitis","volume":"4","author":"Roth","year":"2015","journal-title":"Chin. Clin Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0275","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00066-010-2100-y","article-title":"DEGRO practical guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis","volume":"186","author":"Feyer","year":"2010","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0280","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1468-1331.2006.01506.x","article-title":"EFNS guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force","volume":"13","author":"Soffietti","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0285","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/cncr.24041","article-title":"Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features","volume":"115","author":"Bruna","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0290","series-title":"Neurobiology of Cerebrospinal Fluid 1","first-page":"561","article-title":"Pharmacology of antineoplastic agents in cerebrospinal fluid","author":"Poplack","year":"1980"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0295","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S1470-2045(10)70034-6","article-title":"Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours","volume":"11","author":"Beauchesne","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0300","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1053\/j.seminoncol.2009.05.006","article-title":"Treatment modalities for leptomeningeal metastases","volume":"36","author":"Shapiro","year":"2009","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0305","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11060-013-1244-x","article-title":"Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa","volume":"115","author":"Comte","year":"2013","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0310","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","article-title":"Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis","volume":"11","author":"Grossman","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0315","first-page":"3394","article-title":"A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors","volume":"5","author":"Glantz","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0320","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","article-title":"Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis","volume":"17","author":"Glantz","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0325","unstructured":"A randomized phase III\/IV study to determine benefit and safety of cytarabine liposome injection for treatment of neoplastic meningitis, J. Clin. Oncol. 24, 18_Suppl. http:\/\/ascopubs.org\/doi\/abs\/10.1200\/jco.2006.24.18_suppl.1528. (Accessed 13 December 2017)."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-200544010-00001","article-title":"Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis","volume":"44","author":"Fleischhack","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0335","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.ejca.2004.08.012","article-title":"The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study","volume":"40","author":"Boogerd","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0340","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00277-008-0645-y","article-title":"Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities","volume":"88","author":"Kwong","year":"2009","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0345","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11060-012-0880-x","article-title":"Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series","volume":"109","author":"Chamberlain","year":"2012","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0350","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM197310112891503","article-title":"Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia","volume":"289","author":"Bleyer","year":"1973","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0355","first-page":"1549","article-title":"Treatment of neoplastic meningitis with intraventricular thiotepa and methotrexate","volume":"66","author":"Trump","year":"1982","journal-title":"Cancer Treat. Rep."},{"issue":"Suppl. 7","key":"10.1016\/j.clineuro.2018.07.001_bib0360","doi-asserted-by":"crossref","first-page":"vii11","DOI":"10.1093\/annonc\/mds232","article-title":"Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Cardoso","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0365","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-013-2525-y","article-title":"Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis","volume":"139","author":"Zagouri","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0370","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1345\/aph.1P197","article-title":"Role of intrathecal rituximab and trastuzumab in the management of leptomeningeal carcinomatosis","volume":"44","author":"Perissinotti","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0375","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1005999228846","article-title":"Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy?","volume":"38","author":"Siegal","year":"1998","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0380","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1","article-title":"Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy","volume":"82","author":"Bokstein","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0385","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/1097-0142(19910315)67:6<1685::AID-CNCR2820670635>3.0.CO;2-M","article-title":"Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment","volume":"67","author":"Boogerd","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0390","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3171\/jns.1981.55.3.0445","article-title":"Alteration of blood-CSF barrier by tumor invasion into the meninges","volume":"55","author":"Ushio","year":"1981","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0395","first-page":"1232","article-title":"Chemotherapy of experimental meningeal carcinomatosis","volume":"37","author":"Ushio","year":"1977","journal-title":"Cancer Res."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0400","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00150615","article-title":"Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration study","volume":"4","author":"Siegal","year":"1987","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0405","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4","article-title":"Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen","volume":"77","author":"Fizazi","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0410","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.1998.16.4.1561","article-title":"High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?","volume":"16","author":"Glantz","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0415","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11060-007-9409-0","article-title":"Capecitabine therapy of central nervous system metastases from breast cancer","volume":"85","author":"Ekenel","year":"2007","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0420","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3816\/CBC.2006.n.028","article-title":"Long-term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report","volume":"7","author":"Tham","year":"2006","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0425","doi-asserted-by":"crossref","first-page":"208","DOI":"10.12659\/AJCR.901812","article-title":"Metronomic capecitabine effectively blocks leptomeningeal carcinomatosis from breast cancer: a case report and literature review","volume":"18","author":"Maur","year":"2017","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0430","first-page":"141","article-title":"The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: a systematic review and pooled analysis","volume":"84","author":"Petrelli","year":"2017","journal-title":"Eur. J. Cancer Oxf. Engl. 1990"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0435","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12282-008-0056-x","article-title":"Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report","volume":"16","author":"Shigekawa","year":"2009","journal-title":"Breast Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0440","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1158\/1078-0432.CCR-03-0807","article-title":"Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients","volume":"10","author":"Ostermann","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0445","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1200\/JCO.2004.07.165","article-title":"Pilot phase II trial of temozolomide for leptomeningeal metastases: preliminary report","volume":"22","author":"Davis","year":"2003","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0450","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.bjc.6601953","article-title":"Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value","volume":"91","author":"Herrlinger","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0455","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1212\/01.wnl.0000178981.39984.c2","article-title":"CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases","volume":"65","author":"Reijneveld","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0460","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2362.2003.01056.x","article-title":"Angiostatin prolongs the survival of mice with leptomeningeal metastases","volume":"33","author":"Reijneveld","year":"2003","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0465","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12885-015-1290-1","article-title":"A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis","volume":"15","author":"Wu","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0470","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jfma.2015.03.005","article-title":"Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis","volume":"115","author":"Chen","year":"2016","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0475","first-page":"85","article-title":"A pilot study of systemically administeres bevacizumab in patients with neoplastic maningitis: imaging, clinical, CSF, and biomarker outcomes","volume":"13","author":"Groves","year":"2011","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0480","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s10147-011-0195-5","article-title":"Objective response with lapatinib in patients with meningitis carcinomatosa derived from HER2\/HER1-negative breast cancer","volume":"16","author":"Onishi","year":"2011","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0485","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/sj.bjc.6605343","article-title":"Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies","volume":"101","author":"Toi","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0490","first-page":"166","article-title":"Advances in the systemic treatment of leptomeningeal cancer","volume":"10","author":"Abu Hejleh","year":"2012","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0495","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11060-010-0268-8","article-title":"Prolonged survival of neoplastic meningitis from breast cancer with letrozole and intrathecal methotrexate: a case report","volume":"101","author":"Peroukides","year":"2011","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0500","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1016\/S1470-2045(12)70266-8","article-title":"Epilepsy meets cancer: when, why, and what to do about it?","volume":"13","author":"Weller","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0505","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11060-011-0689-z","article-title":"Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life","volume":"106","author":"Maschio","year":"2012","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0510","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM197507242930402","article-title":"Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections","volume":"293","author":"Shapiro","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0515","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1005991027029","article-title":"Reservoir systems for intraventricular chemotherapy","volume":"38","author":"Berweiler","year":"1998","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0520","first-page":"49","article-title":"Ommaya reservoirs for the treatment of leptomeningeal metastases","volume":"47","author":"Sandberg","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0525","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00146082","article-title":"Fabrication and testing of a device capable of reducing the incidence of ventricular shunt promoted metastasis","volume":"27","author":"Halperin","year":"1996","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0530","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00006565-200304000-00015","article-title":"Ventriculoperitoneal shunt management","volume":"19","author":"Isaacman","year":"2003","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0535","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3171\/jns.1999.91.1.0026","article-title":"Experience with a programmable valve shunt system","volume":"91","author":"Yamashita","year":"1999","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0540","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1212\/01.WNL.0000160396.69050.DC","article-title":"Ventriculoperitoneal shunt in patients with leptomeningeal metastasis","volume":"64","author":"Omuro","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0545","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/cncr.21828","article-title":"Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis","volume":"106","author":"Chamberlain","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0550","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1215\/15228517-2007-059","article-title":"A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies","volume":"10","author":"Groves","year":"2008","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0555","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.2003.04.053","article-title":"Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis","volume":"21","author":"Blaney","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0560","first-page":"484","article-title":"Leptomeningeal metastases: a RANO proposal for response criteria","volume":"19","author":"Chamberlain","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.clineuro.2018.07.001_bib0565","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clinthera.2005.01.005","article-title":"Capecitabine: a review","volume":"27","author":"Walko","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.clineuro.2018.07.001_bib0570","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000313531","article-title":"Study of low-dose capecitabine monotherapy for metastatic breast cancer","volume":"56","author":"Taguchi","year":"2010","journal-title":"Chemotherapy"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846718302671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846718302671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T09:09:05Z","timestamp":1604567345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846718302671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":114,"alternative-id":["S0303846718302671"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2018.07.001","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of leptomeningeal metastasis in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2018.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}